CRISPR Therapeutics (CRSP) PT Lowered to $6 at Baird

February 13, 2026 8:50 AM EST Send to a Friend
Baird analyst Jack Allen lowered ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login